Published in Health Psychol on May 01, 2000
Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol (1993) 6.94
Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer (1977) 5.58
Perceived stress, quitting smoking, and smoking relapse. Health Psychol (1990) 3.26
Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med (2001) 3.11
Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res (2001) 2.98
Social support and smoking cessation and maintenance. J Consult Clin Psychol (1986) 2.92
Biochemical validation of smoking status: pros, cons, and data from four low-intensity intervention trials. Addict Behav (1994) 2.77
Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem (1989) 2.77
Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol (1989) 2.72
Nurse-assisted counseling for smokers in primary care. Ann Intern Med (1993) 2.51
Understanding and preventing relapse. Am Psychol (1986) 2.49
Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest (1999) 2.44
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A (1995) 2.41
Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem (2001) 2.31
Cost-effectiveness of a hospital-based smoking cessation intervention. Med Care (1998) 2.31
Partner behaviors that support quitting smoking. J Consult Clin Psychol (1990) 2.20
Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (2003) 2.20
Pediatric office-based smoking intervention: impact on maternal smoking and relapse. Pediatrics (1995) 2.19
Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem (1998) 2.15
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98
Self-efficacy and relapse in smoking cessation programs. J Consult Clin Psychol (1981) 1.92
Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation. Am J Physiol Gastrointest Liver Physiol (2000) 1.83
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res (1998) 1.81
Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem (1995) 1.78
Work site-based cancer prevention: primary results from the Working Well Trial. Am J Public Health (1996) 1.74
Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem (1995) 1.71
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A (1994) 1.66
The binding of human and guinea-pig IgG subclasses to homologous macrophage and monocyte Fc receptors. Immunology (1978) 1.64
Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol (1995) 1.56
Classification and prediction of smoking relapse episodes: an exploration of individual differences. J Consult Clin Psychol (1988) 1.55
Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J Clin Invest (1988) 1.53
Self-efficacy and smoking reexamined: construct validity and clinical utility. J Consult Clin Psychol (1986) 1.50
The smoking problem: a behavioral perspective. J Consult Clin Psychol (1982) 1.50
Cardiovascular basic helix loop helix factor 1, a novel transcriptional repressor expressed preferentially in the developing and adult cardiovascular system. J Biol Chem (2000) 1.49
Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun (2000) 1.48
Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem (2000) 1.46
Special considerations in ventricular pacing in patients with tricuspid valve disease. Ann Thorac Surg (1983) 1.44
Successful treatment of habitual smokers with warm, smoky air and rapid smoking. J Consult Clin Psychol (1972) 1.42
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med (1999) 1.42
Misonidazole-a drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys (1979) 1.41
Comparison of rapid smoking, warm, smoky air, and attention placebo in the modification of smoking behavior. J Consult Clin Psychol (1973) 1.41
Reducing maternal smoking and relapse: long-term evaluation of a pediatric intervention. Prev Med (1997) 1.40
Universal healthcare: a bold proposal. Conn Med (2000) 1.39
Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem (2000) 1.38
Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation (2000) 1.37
Predictors of smoking during and after pregnancy: a survey of mothers of newborns. Prev Med (1995) 1.37
A self-help cessation program for smokeless tobacco users: comparison of two interventions. Nicotine Tob Res (2000) 1.35
Tobacco cessation interventions in health care settings: rationale, model, outcomes. Addict Behav (1997) 1.34
Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem (1991) 1.34
Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest (1996) 1.33
Partner support and relapse in smoking-cessation programs. J Consult Clin Psychol (1983) 1.32
Changes in adult cigarette smoking in the Minnesota Heart Health Program. Am J Public Health (1995) 1.29
Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem (1997) 1.28
Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant. J Ultrasound Med (1987) 1.28
CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem (2000) 1.27
The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells. Mol Cell Biol (1995) 1.24
Smokeless tobacco use among male adolescents: patterns, correlates, predictors, and the use of other drugs. Prev Med (1987) 1.24
Making the most of a teachable moment: a smokeless-tobacco cessation intervention in the dental office. Am J Public Health (1995) 1.24
Smoking onset among teens: an empirical analysis of initial situations. Addict Behav (1985) 1.23
Some methodological cautions in the use of the Tolerance Questionnaire. Addict Behav (1986) 1.23
Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22
Do smoking prevention programs really work? Attrition and the internal and external validity of an evaluation of a refusal skills training program. J Behav Med (1987) 1.22
Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J Biol Chem (1992) 1.22
A brief smoking cessation intervention for women in low-income planned parenthood clinics. Am J Public Health (2000) 1.21
The medical care system and prevention: the need for a new paradigm. HMO Pract (1998) 1.20
Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. J Biol Chem (1999) 1.20
Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections. J Antimicrob Chemother (1986) 1.19
Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem (2001) 1.19
Maternal smoking cessation and relapse prevention during health care visits. Am J Prev Med (2001) 1.18
Implementing tobacco interventions in the real world of managed care. Tob Control (2000) 1.17
Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest (1995) 1.16
Striated muscle preferentially expressed genes alpha and beta are two serine/threonine protein kinases derived from the same gene as the aortic preferentially expressed gene-1. J Biol Chem (2000) 1.15
Conscientiousness, perceived risk, and risk-reduction behaviors: a preliminary study. Health Psychol (2000) 1.15
Extent and ecological consequences of hunting in Central African rainforests in the twenty-first century. Philos Trans R Soc Lond B Biol Sci (2013) 1.14
Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J Biol Chem (1994) 1.14
A smoking-cessation intervention for hospital patients. Med Care (1993) 1.13
Parent-adolescent problem-solving interactions and drug use. Am J Drug Alcohol Abuse (1990) 1.11
Using the hygiene visit to deliver a tobacco cessation program: results of a randomized clinical trial. J Am Dent Assoc (1998) 1.11
Self-efficacy and relapse in smoking cessation: a replication and extension. J Consult Clin Psychol (1983) 1.10
Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem (1998) 1.09
The effectiveness of workplace smoking cessation programmes: a meta-analysis of recent studies. Tob Control (2004) 1.09
Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest (1996) 1.08
Curvilinear paramedian sternotomy. Ann Thorac Surg (1984) 1.08
Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J Biol Chem (1992) 1.07
Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res (2001) 1.07
Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem (1996) 1.07
Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. Biochemistry (1996) 1.04
Promoting smoking abstinence in pregnant and postpartum patients: a comparison of 2 approaches. Am J Manag Care (2001) 1.04
Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circ Res (1997) 1.03
Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells. J Clin Invest (1996) 1.03
Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J Exp Med (2000) 1.02